AAAAAA

   
Results: 1-21 |
Results: 21

Authors: Fukudome, K Fujimoto, S Kinoshita, H Hara, S Hisanaga, S Eto, T
Citation: K. Fukudome et al., Long-term change of glomerular gelatinolytic activity in rats with streptozotocin-induced diabetes, NEPHROLOGY, 6(5), 2001, pp. 208-213

Authors: Tokura, T Kinoshita, H Fujimoto, S Hisanaga, S Kitamura, K Eto, T
Citation: T. Tokura et al., Plasma levels of mature form of adrenomedullin in patients with haemodialysis, NEPH DIAL T, 16(4), 2001, pp. 783-786

Authors: Kinoshita, H Fujimoto, S Tokura, T Hisanaga, S Kitamura, K Eto, T
Citation: H. Kinoshita et al., Plasma mature form of adrenomedullin in diabetic nephropathy, INTERN MED, 40(8), 2001, pp. 841-842

Authors: Uchida, A Komiya, Y Tashiro, T Yorifuji, H Kishimoto, T Nabeshima, Y Hisanaga, S
Citation: A. Uchida et al., Neurofilaments of Klotho, the mutant mouse prematurely displaying symptomsresembling human aging, J NEUROSC R, 64(4), 2001, pp. 364-370

Authors: Kinoshita, H Uezono, S Fukudome, K Yokota, N Hisanaga, S Fujimoto, S Eto, T
Citation: H. Kinoshita et al., Serum remnant lipoprotein levels in nephrotic syndrome, CLIN NEPHR, 55(3), 2001, pp. 263-264

Authors: Fukudome, K Fujimoto, S Sato, Y Hisanaga, S Eto, T
Citation: K. Fukudome et al., Peritonitis increases MMP-9 activity in peritoneal effluent from CAPD patients, NEPHRON, 87(1), 2001, pp. 35-41

Authors: Chang, W Gruber, D Chari, S Kitazawa, H Hamazumi, Y Hisanaga, S Bulinski, JC
Citation: W. Chang et al., Phosphorylation of MAP4 affects microtubule properties and cell cycle progression, J CELL SCI, 114(15), 2001, pp. 2879-2887

Authors: Bibbb, JA Nishi, A O'Callaghan, JP Ule, J Lan, M Snyder, GL Horiuchi, A Saito, T Hisanaga, S Czernik, AJ Nairn, AC Greengard, P
Citation: Ja. Bibbb et al., Phosphorylation of protein phosphatase inhibitor-1 by Cdk5, J BIOL CHEM, 276(17), 2001, pp. 14490-14497

Authors: Taniguchi, S Fujita, Y Hayashi, S Kakita, A Takahashi, H Murayama, S Saido, TC Hisanaga, S Iwatsubo, T Hasegawa, M
Citation: S. Taniguchi et al., Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains, FEBS LETTER, 489(1), 2001, pp. 46-50

Authors: Kitazawa, H Iida, J Uchida, A Haino-Fukushima, K Itoh, TJ Hotani, H Ookata, K Murofushi, H Bulinski, JC Kishimoto, T Hisanaga, S
Citation: H. Kitazawa et al., Ser787 in the proline-rich region of human MAP4 is a critical phosphorylation site that reduces its activity to promote tubulin polymerization, CELL STRUCT, 25(1), 2000, pp. 33-39

Authors: Kinoshita, H Kato, K Kuroki, M Nakamura, S Kitamura, K Hisanaga, S Fujimoto, S Eto, T
Citation: H. Kinoshita et al., Plasma adrenomedullin levels in patients with diabetes, DIABET CARE, 23(2), 2000, pp. 253-254

Authors: Kinoshita, H Fujimoto, S Kitamura, K Matsuura, Y Uezono, S Hisanaga, S Eto, T
Citation: H. Kinoshita et al., Increased plasma levels of mature adrenomedullin in chronic glomerulonephritis, NEPHRON, 86(3), 2000, pp. 333-338

Authors: Fujimoto, S Kinoshita, H Hara, S Nakazato, M Hisanaga, S Eto, T
Citation: S. Fujimoto et al., Immunohistochemical localization of uroguanylin in the human kidney, NEPHRON, 84(1), 2000, pp. 88-89

Authors: Tokuoka, H Saito, T Yorifuji, H Wei, FY Kishimoto, T Hisanaga, S
Citation: H. Tokuoka et al., Brain-derived neurotrophic factor-induced phosphorylation of neurofilament-H subunit in primary cultures of embryo rat cortical neurons, J CELL SCI, 113(6), 2000, pp. 1059-1068

Authors: Kusakawa, G Saito, T Onuki, R Ishiguro, K Kishimoto, T Hisanaga, S
Citation: G. Kusakawa et al., Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25, J BIOL CHEM, 275(22), 2000, pp. 17166-17172

Authors: Srsen, V Kitazawa, H Sugita, M Murofushi, H Bulinski, JC Kishimoto, T Hisanaga, S
Citation: V. Srsen et al., Serum-dependent phosphorylation of human MAP4 at Ser696 in cultured mammalian cells, CELL STRUCT, 24(5), 1999, pp. 321-327

Authors: Uchida, A Yorifuji, H Lee, VMY Kishimoto, T Hisanaga, S
Citation: A. Uchida et al., Neurofilaments of aged rats: The strengthened interneurofilament interaction and the reduced amount of NF-M, J NEUROSC R, 58(2), 1999, pp. 337-348

Authors: Ishihara, T Yokota, N Hisanaga, S Fujimoto, S Hirayama, N Kato, J Kitamura, K Eto, T
Citation: T. Ishihara et al., Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failure, CLIN NEPHR, 52(2), 1999, pp. 119-123

Authors: Kinoshita, H Fujimoto, S Kitamura, K Yokota, N Kawamoto, M Tokura, T Hisanaga, S Eto, T
Citation: H. Kinoshita et al., Plasma and urine levels of adrenomedullin and proadrenomedullin N-terminal20 peptide in chronic glomerulonephritis, AM J KIDNEY, 34(1), 1999, pp. 114-119

Authors: Kinoshita, H Fujimoto, S Fukae, H Yokota, N Hisanaga, S Nakazato, M Eto, T
Citation: H. Kinoshita et al., Plasma and urine levels of uroguanylin, a new natriuretic peptide, in nephrotic syndrome, NEPHRON, 81(2), 1999, pp. 160-164

Authors: Saito, T Ishiguro, K Onuki, R Nagai, Y Kishimoto, T Hisanaga, S
Citation: T. Saito et al., Okadaic acid-stimulated degradation of p35, an activator of CDK5, by proteasome in cultured neurons, BIOC BIOP R, 252(3), 1998, pp. 775-778
Risultati: 1-21 |